Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
0.867
-0.019 (-2.19%)
Dec 20, 2024, 4:00 PM EST - Market closed
Vor Biopharma Employees
Vor Biopharma had 168 employees as of December 31, 2023. The number of employees increased by 35 or 26.32% compared to the previous year.
Employees
168
Change (1Y)
35
Growth (1Y)
26.32%
Revenue / Employee
n/a
Profits / Employee
-$669,423
Market Cap
59.56M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 168 | 35 | 26.32% |
Dec 31, 2022 | 133 | -2 | -1.48% |
Dec 31, 2021 | 135 | 47 | 53.41% |
Dec 31, 2020 | 88 | - | - |
Related Stocks
Company Name | Employees |
---|---|
WORK Medical Technology Group LTD | 216 |
DBV Technologies | 105 |
IceCure Medical | 77 |
Forian | 37 |
BeyondSpring | 36 |
Oncolytics Biotech | 29 |
Milestone Scientific | 17 |
Annovis Bio | 16 |
VOR News
- 12 days ago - Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback from FDA Regarding Registrational Trial Design - GlobeNewsWire
- 2 months ago - Vor Bio Appoints Seasoned Healthcare Institutional Investor, Han Choi, M.D., LL.M., as Chief Financial Officer - GlobeNewsWire
- 3 months ago - What's Going On With Penny Stock Blood Cancer-Focused Vor Biopharma On Friday? - Benzinga
- 3 months ago - New Clinical Data Validates Vor Bio's Approach of Using Shielded Transplants to Deliver Targeted Therapies - GlobeNewsWire
- 4 months ago - Vor Bio to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 4 months ago - Vor Bio Reports Second Quarter 2024 Financial Results and Provides Company Update - GlobeNewsWire
- 5 months ago - Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 8 months ago - Vor Bio Reports First Quarter 2024 Financial Results and Provides Company Update - GlobeNewsWire